This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Vafiadis, P. Articles by Polychronakos, C. Search for Related Content PubMed PubMed Citation Articles by Vafiadis, P. Articles by Polychronakos, C. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information Diabetes Type 1

Divergence between Genetic Determinants of IGF2 Transcription Levels in Leukocytes and of IDDM2-Encoded Susceptibility to Type 1 Diabetes¹

McGill University-Montreal Children’s Hospital Research Institute and the Department of Pediatrics, Division of Endocrinology, McGill University (P.V., R.G., C.P.), Montreal, Quebec, Canada H3H 1P3; and the Wellcome Trust Center for Human Genetics, Nuffield Department of Surgery, University of Oxford (S.T.B., J.A.T.), Oxford, United Kingdom OX3 7BN

Address all correspondence and requests for reprints to: Constantin Polychronakos, M.D., F.R.C.P.(C), Montreal Children’s Hospital, 2300 Tupper Street, Montreal, Quebec, Canada H3H 1P3. E-mail: mc97{at}musica.mcgill.ca

The IDDM2 susceptibility locus in type 1 diabetes corresponds to a variable number of tandem repeats (VNTR) upstream of the insulin (INS) and insulin-like growth factor 2 (IGF2) genes. Large VNTR alleles (class III) are dominantly protective, whereas small alleles (class I) are predisposing. IGF2 has been considered a prime candidate for mediating IDDM2-encoded susceptibility because of its proximity to the VNTR, mitogenic properties and parental effects at IDDM2 suggest the involvement of an imprinted gene. IGF2 is imprinted with exclusive expression of the paternal gene. However, there is polymorphic relaxation of IGF2 imprinting in leukocytes. VNTR allelic variation affecting either the extent of relaxation or transcription independent of parental origin might explain the IDDM2 effect. To test this, we compared IGF2 expression between chromosomes with a class III or I allele in leukocytes and stimulated lymphocytes. No significant difference was detected between the two classes. Furthermore, the (+) allele of an ApaI polymorphism in the 3'-untranslated region of IGF2 was associated with significantly higher IGF2 messenger ribonucleic acid levels than the (-) allele, but was not associated with type 1 diabetes. The absence of transcriptional effects in leukocytes on IGF2 by the VNTR, which is the disease-predisposing locus, and the presence of a strong association between IGF2 levels and ApaI, which is not associated with the disease, argue against IGF2 expression in leukocytes as the mediator of IDDM2-encoded susceptibility. Taken together, these results support studies suggesting that INS expression in the thymus is a primary target of the IDDM2 susceptibility locus.

This article has been cited by other articles:

				R. Bachner-Melman, A. H. Zohar, L. Nemanov, U. Heresco-Levy, I. Gritsenko, and R. P. Ebstein Association Between the Insulin-Like Growth Factor 2 Gene (IGF2) and Scores on the Eating Attitudes Test in Nonclinical Subjects: A Family-Based Study Am J Psychiatry, December 1, 2005; 162(12): 2256 - 2262. [Abstract] [Full Text] [PDF]

				I. Durinovic-Bello, E. Jelinek, M. Schlosser, T. Eiermann, B. O. Boehm, W. Karges, L. Marchand, and C. Polychronakos Class III Alleles at the Insulin VNTR Polymorphism Are Associated With Regulatory T-Cell Responses to Proinsulin Epitopes in HLA-DR4, DQ8 Individuals Diabetes, December 1, 2005; 54(suppl_2): S18 - S24. [Abstract] [Full Text] [PDF]

				M. S. Sandhu, B. Heude, E. H. Young, R. Luben, J. Luan, K.-T. Khaw, J. Todd, and N. J. Wareham INS VNTR Class Genotype and Indexes of Body Size and Obesity: Population-Based Studies of 7,999 Middle-Aged Men and Women Diabetes, September 1, 2005; 54(9): 2812 - 2815. [Abstract] [Full Text] [PDF]

				H. F. Escobar-Morreale, M. Luque-Ramirez, and J. L. San Millan The Molecular-Genetic Basis of Functional Hyperandrogenism and the Polycystic Ovary Syndrome Endocr. Rev., April 1, 2005; 26(2): 251 - 282. [Abstract] [Full Text] [PDF]

				M. A. Schrager, S. M. Roth, R. E. Ferrell, E. J. Metter, E. Russek-Cohen, N. A. Lynch, R. S. Lindle, and B. F. Hurley Insulin-like growth factor-2 genotype, fat-free mass, and muscle performance across the adult life span J Appl Physiol, December 1, 2004; 97(6): 2176 - 2183. [Abstract] [Full Text] [PDF]

				J. A. McCann, Y. Q. Xu, R. Frechette, L. Guazzarotti, and C. Polychronakos The Insulin-Like Growth Factor-II Receptor Gene Is Associated with Type 1 Diabetes: Evidence of a Maternal Effect J. Clin. Endocrinol. Metab., November 1, 2004; 89(11): 5700 - 5706. [Abstract] [Full Text] [PDF]

				J. L. San Millan, M. Corton, G. Villuendas, J. Sancho, B. Peral, and H. F. Escobar-Morreale Association of the Polycystic Ovary Syndrome with Genomic Variants Related to Insulin Resistance, Type 2 Diabetes Mellitus, and Obesity J. Clin. Endocrinol. Metab., June 1, 2004; 89(6): 2640 - 2646. [Abstract] [Full Text] [PDF]

				M A Kelly, M L Rayner, C H Mijovic, and A H Barnett Molecular aspects of type 1 diabetes Mol. Pathol., February 1, 2003; 56(1): 1 - 10. [Abstract] [Full Text] [PDF]